30.04.2014 • NewsDede WillamsPharmaPharmaceuticals

Sanofi Said Eyeing Drug Divestments of Over $7 Billion

French pharmaceutical producer Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, the news agency Reuters said, quoting unnamed sources.

The drugmaker, believed to working with Evercore Partners, is said to have contacted potential buyers.

The drugs for sale would include treatments for high blood pressure and cardio-metabolic diseases and have roughly $3.7 billion in combined annual revenue, a source told the news agency, adding that the portfolio could fetch up to two times that amount.

Generic drugmakers and specialty pharmaceutical companies are seen as logical buyers for the Sanofi drug portfolio.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis